Can vitamin K cause pulmonary embolism in a patient one month after below‑knee amputation who has had multiple falls at home?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Vitamin K Does NOT Cause Pulmonary Embolism

Vitamin K supplementation does not cause pulmonary embolism (PE); rather, this patient is at high risk for PE due to the recent below-knee amputation, and vitamin K may actually be counteracting necessary anticoagulation if they were prescribed it for VTE prevention.

Critical Clinical Context

The key issue here is determining why this patient is taking vitamin K one month post-amputation:

If Taking Vitamin K Antagonist (Warfarin) for VTE Prevention:

  • Vitamin K supplementation would be dangerous as it directly antagonizes warfarin's anticoagulant effect 1
  • This could lead to subtherapeutic anticoagulation and increase PE risk
  • The FDA label clearly states vitamin K reverses warfarin anticoagulation 1

If Taking Vitamin K as a Supplement:

  • Vitamin K itself does not cause thrombosis or PE 2
  • However, it can interfere with any concurrent warfarin therapy

The Real PE Risk: Post-Amputation Thromboembolism

Lower extremity amputation carries substantial VTE risk that extends well beyond the immediate perioperative period:

  • Patients requiring lower extremity amputation are at high risk for venous thrombosis and PE 3
  • Historical data shows PE was documented in multiple amputation patients, with many cases going clinically unrecognized 3
  • One case report documented PE with hypercoagulability (protein C deficiency) following above-knee amputation 4

Current guidelines recommend therapeutic anticoagulation for ≥3 months for PE/VTE secondary to major transient/reversible risk factors (which includes surgery) 5. At one month post-BKA, this patient should still be on therapeutic anticoagulation.

Critical Assessment Needed

Immediate Actions:

  1. Verify anticoagulation status: Is the patient on warfarin or another anticoagulant?
  2. Check INR if on warfarin: Vitamin K supplementation could have rendered them subtherapeutic
  3. Evaluate for PE clinically: Multiple falls could be syncope from PE rather than mechanical instability
  4. Consider imaging: D-dimer, CT pulmonary angiography if clinical suspicion warrants

Common Pitfall:

The multiple falls may actually be symptoms of PE (syncope, dyspnea, hypoxia causing weakness) rather than a separate issue. Don't assume falls are purely mechanical/prosthetic-related in a post-amputation patient.

Bottom Line

Vitamin K does not cause PE, but inappropriate vitamin K use in a patient who should be anticoagulated post-amputation could increase PE risk by reversing necessary anticoagulation 1. The patient's recent BKA itself is a major risk factor for VTE requiring 3 months of therapeutic anticoagulation 5. Urgent evaluation for both PE and anticoagulation adequacy is warranted.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.